• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

In vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: differential regulation by interleukin-1 alpha and glucocorticoids.

作者信息

Grosset C, Jazwiec B, Taupin J L, Liu H, Richard S, Mahon F X, Reiffers J, Moreau J F, Ripoche J

机构信息

Laboratoire de Greffe de Moelle, Université de Bordeaux II, France.

出版信息

Blood. 1995 Nov 15;86(10):3763-70.

PMID:7579343
Abstract

Endothelial cell (EC) may represent a major source of cytokines in the bone marrow. In this study we have examined the production and the regulation of the production of leukemia inhibitory factor/human interleukin for DA cells (LIF/HILDA) by EC. Human umbilical vein endothelial cells (HUVEC) were chosen as a working model as they are a well known source of cytokines. These cells secrete LIF/HILDA (90 pg/mL/10(6) cells/48 h) in basal conditions. This secretion is profoundly altered by interleukin-1 alpha (IL-1 alpha). Secretion of LIF/HILDA is increased threefold on stimulation with IL-1 alpha at a concentration of 100 IU/mL. The secreted protein is bioactive as demonstrated by its proliferative effects on DA1a cells. Modulation of the production of LIF/HILDA by glucocorticoids (GC) was also examined. In striking contrast to what was observed for IL-1 alpha, the synthetic GC dexamethasone (DXM) at a concentration of 10(-6) mol/L consistently inhibited the basal secretion of LIF/HILDA by an average of threefold and suppressed the IL-1 alpha-induced increase of the secretion of this cytokine by HUVEC. In an effort to extend results obtained with HUVEC to the bone marrow endothelium, we have also examined the production of LIF/HILDA by human bone marrow endothelial cells (HBMEC). Our study shows that HBMEC are quantitatively a very important source of this cytokine (above 7.25 ng/mL/10(6) cells/48 h) suggesting that they are a major source of LIF/HILDA in the bone marrow. Again, IL-1 alpha proved to be a very potent stimulus for the secretion of LIF/HILDA and synthetic GC such as DXM when used at a concentration of 10(-6) mol/L inhibited by an average of threefold the basal secretion of LIF/HILDA and had suppressive effect on the IL-1 alpha-induced increase of this secretion. The downregulation of LIF/HILDA production in the bone marrow by GC may be important to understand the effects of GC on hematopoiesis.

摘要

相似文献

1
In vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: differential regulation by interleukin-1 alpha and glucocorticoids.
Blood. 1995 Nov 15;86(10):3763-70.
2
Leukemia inhibitory factor/human interleukin for DA cells: a growth factor that stimulates the in vitro development of multipotential human hematopoietic progenitors.白血病抑制因子/DA细胞人白细胞介素:一种刺激多能人类造血祖细胞体外发育的生长因子。
Blood. 1991 Jan 15;77(2):263-70.
3
Endothelial cell support of hematopoiesis is differentially altered by IL-1 and glucocorticoids.白细胞介素-1和糖皮质激素对内皮细胞支持造血的作用有不同程度的改变。
Leukemia. 1998 Aug;12(8):1210-20. doi: 10.1038/sj.leu.2401086.
4
Interleukin-4 (IL-4), but not IL-10, regulates the synthesis of IL-6, IL-8 and leukemia inhibitory factor by human bone marrow stromal cells.
Biochim Biophys Acta. 1999 Feb 4;1449(1):83-92. doi: 10.1016/s0167-4889(98)00177-3.
5
Leukaemia inhibitory factor expression is inhibited by glucocorticoids through post-transcriptional mechanisms.
Cytokine. 1999 Jan;11(1):29-36. doi: 10.1006/cyto.1998.0394.
6
Human interleukin for DA cells (HILDA) does not affect the proliferation and differentiation of hematopoietic progenitor cells in human long-term bone marrow cultures.人DA细胞白细胞介素(HILDA)不影响人长期骨髓培养中造血祖细胞的增殖和分化。
Exp Hematol. 1992 Jan;20(1):6-10.
7
Production of human interleukin for DA cells (HILDA)/leukemia inhibitory factor (LIF) by activated monocytes.活化单核细胞产生人DA细胞白细胞介素(HILDA)/白血病抑制因子(LIF)
Cell Immunol. 1990 Oct 1;130(1):50-65. doi: 10.1016/0008-8749(90)90161-j.
8
Induction of leukemia inhibitory factor in human synovial fibroblasts by IL-1 and tumor necrosis factor-alpha.白细胞介素-1和肿瘤坏死因子-α诱导人滑膜成纤维细胞产生白血病抑制因子。
J Immunol. 1993 Feb 15;150(4):1496-502.
9
Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha.长期贴壁层培养中的白血病抑制因子:白血病中生物活性蛋白水平升高以及白细胞介素-4、白细胞介素-1β和肿瘤坏死因子-α的调节作用
Cancer Res. 1994 Apr 1;54(7):1837-42.
10
Expression of leukemia inhibitory factor (LIF)/interleukin-6 family cytokines and receptors during in vitro osteogenesis: differential regulation by dexamethasone and LIF.白血病抑制因子(LIF)/白细胞介素-6家族细胞因子及其受体在体外成骨过程中的表达:地塞米松和LIF的差异调节
Bone. 2002 Jul;31(1):212-9. doi: 10.1016/s8756-3282(02)00806-2.

引用本文的文献

1
Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation.Col3.6-HSD2 转基因小鼠:跨越早期和晚期成骨细胞分化的糖皮质激素功能丧失模型。
Bone. 2010 Sep;47(3):573-82. doi: 10.1016/j.bone.2010.06.002. Epub 2010 Jun 9.
2
Transforming growth factor-{beta} coordinately induces suppressor of cytokine signaling 3 and leukemia inhibitory factor to suppress osteoclast apoptosis.转化生长因子-{beta} 协同诱导细胞因子信号转导抑制因子 3 和白血病抑制因子抑制破骨细胞凋亡。
Endocrinology. 2010 Apr;151(4):1713-22. doi: 10.1210/en.2009-0813. Epub 2010 Feb 24.
3
Induction of astrocyte differentiation by endothelial cells.
内皮细胞诱导星形胶质细胞分化
J Neurosci. 2001 Mar 1;21(5):1538-47. doi: 10.1523/JNEUROSCI.21-05-01538.2001.
4
Ability of various inserts to promote endothelium cell culture for the establishment of coculture models.
Cell Biol Toxicol. 1996 Dec;12(4-6):207-14. doi: 10.1007/BF00438147.
5
Optimization of use of UEA-1 magnetic beads for endothelial cell isolation.用于内皮细胞分离的UEA-1磁珠使用的优化。
Cell Biol Toxicol. 1996 Dec;12(4-6):189-97. doi: 10.1007/BF00438144.